Markets

Insider Trading

Hedge Funds

Retirement

Opinion

12 Most Advanced Countries in Biotechnology

In this article, we take a look at the 12 most advanced countries in biotechnology. You can skip our detailed analysis of the sector and go directly to 5 Most Advanced Countries in Biotechnology.

The Covid-19 pandemic has awoken the world to its vulnerability to airborne viruses whose outbreaks are extremely hard to contain. It certainly wasn’t the last pandemic, as a Nature study shows how loss of biodiversity is likely to increase the frequency of viral outbreaks. 

However, the pandemic was also an occasion that showcased the global biotechnological capability, as Covid vaccines were developed and rolled out within two years, allowing a return to normalcy.

How Big Data and AI are Transforming Biotechnology

Biotechnology, in comparison to many technological fields, is progressing rapidly. Thanks, in part, to AI. In many ways, the field’s progress has been massively boosted by Machine Learning (ML). For example, ML is increasingly being used for protein folding, an important step involved in drug discovery.

Recently, DeepMind, a UK-based AI subsidiary owned by Alphabet Inc. (NASDAQ:GOOG), announced its deep learning program called AlphaFold, which has solved 98.5% of human proteins’ structures. Prior to AlphaFold, the structure of only 17% of human proteins had been solved and it had been a challenge for half a century. 

Other Deep Learning techniques, such as image classification, are increasingly being adopted to detect cancer from medical scans among many other examples of AI in biotechnology. Deep Learning neural networks and big data have also proved to be highly effective in personalized medicine.

Benchsci, a provider of AI health technologies, has tracked the growth of biotechnology startups adopting Machine Learning technologies  and has shown that as of 2021, 230 biotechnology startups are using AI in the solutions they provide across the world. Some of the prominent startups in the industry include Ampilon, BioSymetrics, 3BIGS, BioRelate and Causaly. 

Big Players

Some of the top market players in the biotechnology industry include Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), BioNTech SE (NASDAQ:BNTX), argenx SE (NASDAQ:ARGX) and Galapagos NV (NASDAQ:GLPG).

Pfizer Inc. (NYSE:PFE), BioNTech SE (NASDAQ:BNTX) and Merck & Co., Inc. (NYSE:MRK) are known for significant contributions in helping solve recent disease outbreaks, with vaccines.

Other Biotechnology Trends to Watch in 2023

Another often overlooked but highly lucrative emerging field in biotechnology is the artificial meat industry. The meat and dairy industry’s carbon footprint is leading to a demand for artificial meat/dairy products. Its technology has been pioneered through stem cell research. Some leading US startups in this domain include Memphis Meats, New Age Meats and Finless Foods.

Industry Outlook: 2030

According to Grand View Research, the biotechnology industry is valued at $1 trillion as of 2021. The value is projected to reach nearly $4 trillion in 2030, with a CAGR of 14%

The cultured-meat sub-industry, on the other hand, is in its early phase and is valued at $600 million, going by their funding in 2020 and 2021. McKinsey estimates that the market value of lab-grown meat will reach $25 billion in 2030, as consumer acceptance gradually takes hold. Lab grown meat could account for 0.5% of the global meat supply by that time. 

Some of the top countries in terms of research in biotechnology include Singapore, Sweden, United States, United Kingdom and Germany. 

Below, we list the 12 most advanced countries in biotechnology.

Our Methodology

For our list of the 12 most advanced countries in biotechnology, we’ve ranked them based on a Nature study that evaluated the advancement of biotechnology in different countries based on important factors. 

The first factor was ‘public biotechnology’ that evaluated publicly listed biotech companies. Another pillar is focused on education and considers countries’ efforts in biotech fields in academia, like the number of degrees and students. The last pillar is centered around R&D investments in the biotechnology industry. 

To supplement our list of 12 most advanced countries in biotechnology, we’ve gathered the data from various other credible sources like Labio Tech and Tracxn for the number of companies and startups. 

Let’s dive in.

12. Austria

Number of Biotechnology Companies: 900+

Austria is located in the Southern zone of Central Europe. It is home to over 900 biotechnology companies. The country has over 2,400 researchers in the field working in 55 facilities and is home to 77,000 biotechnology students. 

According to Austrian Biotech, a go-to database for biotechnology in the country, 11.2% of the companies in the biotechnology sector are primarily involved in contract-based Research and Development. 

On the other hand, 22.5% are involved in Diagnostics and Analytical services. Another 27.4% are involved in Therapeutics. Some of the top biotechnology companies working on frontier biotechnologies include Phagomed, which develops viral treatments for bacterial infections and F2G, which develops novel treatments for fungal infections.

11. Germany

Number of Biotechnology Companies: 774+

Germany is one of the most advanced countries in biotechnology. It is overall a highly advanced nation in Europe. In terms of Knowledge-and-Technology-Intensive (KTI) industries, Germany contributed 6% to the overall global KTI output in 2019.

The number of biotechnology companies in the county has grown to over 774 as of 2021. As far as academia goes, there are 36 different biotechnology degrees offered in 33 universities in Germany, per Erudera.  

One of the most prominent biotechnology companies in Germany is BioNTech SE (NASDAQ:BNTX), which, as mentioned earlier, was involved in the development of the Pfizer-BioNTech vaccine for Covid-19, in collaboration with the American corporation Pfizer Inc. (NYSE:PFE).

10. Belgium

Number of Biotechnology Companies: 140+

Belgium is located in Northwestern Europe. It has over 140 biotechnology companies as of 2021, according to the leading Biotech news platform, Labio Tech. 

Belgian corporations account for almost 24% of the overall stock value of all biotechnology companies in Europe according to Flanders Investment and Trade. Its top players include argenx SE (NASDAQ:ARGX) and Galapagos NV (NASDAQ:GLPG).

9. Finland

Number of Biotechnology Companies: 120+

Finland is located in Northern Europe. It is one of the most advanced countries in terms of the biotechnology industry. According to rough estimates, the country is home to over 120 biotech companies as of 2021. 

Digital Health happens to be one of the fastest growing sub-industries within the broader sector. Its other strengths are in genomics and clinical analysis. It is largely thanks to the project FinnGen, a government funded project that was intended to obtain the genomic data of 500,000 citizens, 10% of the Finnish population. It is one of the most ambitious projects in the world.

8. Israel

Number of Biotechnology Companies: 160

Israel is located in the Middle East and is the most technologically advanced country in the region. It is home to 160 biotechnology companies as of 2021, according to Jewish Virtual Library. 

Some of the top startups in the country working in the industry include 1E Therapeutics, Future Meat and ReMilk. 1E Therapeutics is developing RNA-oriented treatments against various diseases. As of 2021, the startup has received $120 million in seed investments, as reported by Labio Tech. 

The other two — Future Meat and ReMilk — are working on developing lab meat and sustainable milk (using genetically modified yeast) respectively.

7. United Kingdom

Number of Biotechnology Companies: 415

The United Kingdom is the seventh on the list of most advanced countries in biotechnology. Around 415 Biotech companies are of British origin in Europe according to McKinsey. Between 2018-2020, 22 new biotechnology companies were founded in the country. 

It is one of the top three European countries with companies that are pursuing novel biotechnological solutions in areas like immunotherapy. Biotech startups in the country have an easier time securing early-stage funding than other countries in Europe but the UK lags behind China and the US in the average amount, by $25 million and $15 million, respectively. 

Some of the biotech startups to watch for in the country include Genomics, Healx and Bit Bio. Genomics is working in genomic-sequence analysis and interpretation and has secured $71 million in funding. Healx is another startup in the genomics domain, with $68 million in funding.  Bit Bio, on the other hand, is working in cell therapies and has $50 million in funding as of 2020. 

Apart from its own corporations and startups, the UK also hosts many global corporations like Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), Eli Lilly and Company (NYSE:LLY), argenx SE (NASDAQ:ARGX), Novo Nordisk A/S (NYSE:NVO), BioNTech SE (NASDAQ:BNTX) and Galapagos NV (NASDAQ:GLPG).

6. Singapore

Number of Biotechnology Companies: 350+

Singapore is a city state located in Southeast Asia. The country is home to over 350 biotechnology companies as of 2022. Some top companies include Tessa Therapeutics, Biosensors and AUM Biosciences. 

However, they’re not quite as big in scale as global companies like Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), argenx SE (NASDAQ:ARGX), BioNTech SE (NASDAQ:BNTX) and Galapagos NV (NASDAQ:GLPG)

The top startups in Singapore include Holmusk, ETBio, CoFormula and Kinnva. Singapore’s biotech R&D is highly impactful, primarily due to its world-renowned high quality educational institutes. For a country with a population of only 5.4 million in 2021, Singapore received over 2,000 patent applications in the same year from its residents.

Click to continue reading and see 5 Most Advanced Countries in Biotechnology.

Suggested articles:

Disclosure: none. 12 Most Advanced Countries in Biotechnology is originally published on Insider Monkey.

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

  • It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
  • It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
  • It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

  • The AI infrastructure supercycle
  • The onshoring boom driven by Trump-era tariffs
  • A surge in U.S. LNG exports
  • And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…